Discover how Prolytix’s cutting-edge solutions and personalized approach can accelerate and de-risk your program. Whether you need large molecule drug discovery and development support, protein chemistry services, high-quality critical regents, or custom collection devices, we’re your trusted partner. From R&D to GxP services, there’s only one way to go — with the pro.
Advance Your Biotherapeutic Development With Prolytix Read More »
Trust Prolytix to provide data that are not only accurate but also optimally resolved, driving greater confidence in your excipient analysis results. Download our resource to learn more.
Revolutionizing Polysorbate Analysis in Biotherapeutics Read More »
Developing novel biotherapeutics that are safe and effective requires a strategic and collaborative approach. At Prolytix, we offer integrated bioanalytical services that span your product’s entire life cycle, providing you with critical insights for confident decisions. Download our fact sheet to learn more.
Integrated Bioanalytical Services for Biotherapeutics | Fact Sheet Read More »
De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Download our white paper to learn what you need to know with regard to new biomarker assay development.
Biomarker-Specific De Novo Assay Development Guide Read More »
This technical white paper details Prolytix’s mixed-mode high-performance liquid chromatography method for the determination of polysorbates, such as PS80. The method offers notable improvements over a conventional reverse-phase HPLC method. The paper includes discussion of:
White Paper: Improving PS80 Detection in Drug Product Formulations Read More »
Realizing the therapies of the future requires ongoing innovation and measurable advancements in biotherapeutic development. In this blog, we look at three essential ways that this is currently being achieved: A commitment to the highest levels of excellence in science, as well as prioritizing collaboration between our scientists and the clients that come to Prolytix
What’s Driving Biotherapeutic Innovation Today? Read More »
Choosing the right bioanalytical CRO partner is one of the most important decisions you’ll make in the development of your drug. For comprehensive characterization that enables you to make your biggest decisions with confidence, go with the pro — Prolytix.
HRMS HCP Analysis: The Prolytix Difference | Fact Sheet Read More »
Picking a partner for your biotherapeutic program is one of the most crucial decisions you’ll make. When you partner with a CRO, you’re melding outside expertise and resources with your internal knowledge base to expand and accelerate your problem-solving capabilities. This is a tremendous gain, but it’s important to remember that you are the client,
How to Choose the Right CRO for Your Program Read More »
Choosing the appropriate analytical and bioanalytical CRO partner is critical to the success of your biotherapeutic drug development program. Selecting the wrong partner could delay timelines and increase costs, putting your innovation at risk. For large molecule and protein chemistry expertise to accelerate your drug development, go with the pro — Prolytix. Download Now:
From Process Development to GMP Release: A Full-Service Approach | Fact Sheet Read More »
Explore our work with a highly efficient method of plasma fractionation that could revolutionize IVIG production in this process talk by Matthew Whelihan, Ph.D. Download Now:
